University of Pittsburgh Cancer Institute DeptofMageeWomen'sHospital(2) is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
University of Pittsburgh Cancer Institute DeptofMageeWomen'sHospital(2) has participated in 1 clinical trials.
Therapeutic areas: HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pittsburgh Cancer Institute DeptofMageeWomen'sHospital(2) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pittsburgh Cancer Institute DeptofMageeWomen'sHospital(2) has 1 clinical trials on record. Their work covers HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer.
University of Pittsburgh Cancer Institute DeptofMageeWomen'sHospital(2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.